Vaping and oral snuff products containing synthetic nicotine analogues have been found in the US marketplace this year. These products are promoted as exempt from the US Food and Drug Administration (FDA) premarket tobacco product application (PMTA) process and avoid federal and state regulations.
This report explains what nicotine analogues are and what their current US federal legal status is, looks at criticism for the FDA’s lack of regulations on them, and predicts the future of these compounds in the country.
